Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT07017530
Starting soon Not applicable

Cognitive Training and Exercise for Women With Breast Cancer and Cognitive Impairment

NCT07017530 · tracked via the Priya Life Science Spain tracker
Sponsor
Universidad de Extremadura
Phase
Not applicable
Started
2025-09-01
Last updated
2025-06-12

Condition(s) studied

Breast Cancer

Investigational drug(s) / intervention(s)

Cognitive trainingPsychoeducational therapy

Cognitive training: Combined Intervention of Cognitive Training and Supervised Physical Exercise

Psychoeducational therapy: According to standard clinical practice

Study summary

Chemotherapy-related cognitive impairment is a prevalent and distressing condition among breast cancer survivors, adversely affecting memory, attention, and overall cognitive function, thereby diminishing quality of life. Emerging evidence suggests that multimodal interventions combining cognitive training and adapted physical exercise may mitigate these cognitive deficits and associated symptoms. This study aims to evaluate the efficacy of a 12-week structured intervention integrating cognitive training and supervised physical exercise in improving cognitive function, fatigue, sleep quality, psychological distress, and overall well-being in women with breast cancer. Furthermore, it seeks to determine the optimal timing for such interventions to maximize their effectiveness. A randomized controlled trial involving 220 participants will assess subjective and objective cognitive outcomes, brain activity, and physical performance. The findings from this research may contribute to the development of evidence-based rehabilitation strategies, enhancing cognitive health and quality of life in breast cancer patients.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Women aged 18 years or older who were diagnosed with stage 0 to IV breast cancer. * Women undergoing chemotherapy (at least two cycles) or having completed it at least six months earlier. * Cognitive impairment must be reported, with scores below 54 on the FACT-Cog scale Exclusion Criteria: * Women with significant neurological conditions. * Women with psychiatric conditions. * Women with contraindications for physical exercise.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Facultad de Medicina y Ciencias de la Salud Badajoz Badajoz

More Universidad de Extremadura trials in Spain

Study on the Effect of a Gamified Health Education Programme on Primary School Children Recruiting
Protocol for a Natural-Based Intervention to Promote Quality of Life and Healthy Habits on Children and Adolescents. Active, not recruiting
Metabolic Response to Supine Physiotherapy in Mechanically Ventilated ICU Patients Active, not recruiting

Other trials for the same condition

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors Recruiting
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer Active, not recruiting
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial Active, not recruiting
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy Active, not recruiting
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07017530 on ClinicalTrials.gov ↗ ← All trials in Spain